MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, GDRX made $194,006K in revenue. $1,169K in net income. Net profit margin of 0.60%.

Income Overview

Revenue
$194,006K
Net Income
$1,169K
Net Profit Margin
0.60%
Unit: Thousand (K) dollars
Revenue Breakdown
    • Prescription Transactions Revenu...
    • Pharma Manufacturer Solutions Re...
    • Subscription Revenue
    • Other Revenue

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
194,006 194,785 196,028 203,070
Cost of revenue, exclusive of depreciation and amortization presented separately below
20,156 17,464 13,419 13,350
Product development and technology
30,177 28,939 31,012 29,933
Sales and marketing
81,053 78,616 83,532 84,870
General and administrative
26,819 23,937 32,014 28,379
Depreciation and amortization
21,792 23,146 21,431 19,729
Total costs and operating expenses
179,997 172,102 181,408 176,261
Operating income
14,009 22,683 14,620 26,809
Other income (expense)
-24* 0 694
Loss on extinguishment of debt
-0* 0 -
Interest income
1,397 1,889 2,309 2,803
Interest expense
9,767 10,403 10,829 10,729
Total other expense, net
-8,370 -8,490 -8,520 -7,232
Income before income taxes
5,639 14,193 6,100 19,577
Income tax expense
4,470 8,768 4,981 6,734
Net income
1,169 5,425 1,119 12,843
Basic EPS
0 0.016 0 0.04
Diluted EPS
0 0.016 0 0.04
Basic Average Shares
340,531,000 342,713,000 346,776,000 356,623,000
Diluted Average Shares
341,424,000 343,267,000 347,810,000 357,159,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Prescription TransactionsRevenue$113,692K (-23.66%↓ Y/Y)Pharma ManufacturerSolutions Revenues$52,230K (82.32%↑ Y/Y)Subscription Revenue$24,393K (16.06%↑ Y/Y)Other Revenue$3,691K (-15.77%↓ Y/Y)Revenue$194,006K (-4.42%↓ Y/Y)Operating income$14,009K (-40.08%↓ Y/Y)Total costs andoperating expenses$179,997K (0.23%↑ Y/Y)Income before incometaxes$5,639K (-66.17%↓ Y/Y)Total other expense,net-$8,370K (-24.70%↓ Y/Y)Interest income$1,397K (-64.47%↓ Y/Y)Sales and marketing$81,053K (-4.13%↓ Y/Y)Product development andtechnology$30,177K (-3.10%↓ Y/Y)General andadministrative$26,819K (-9.49%↓ Y/Y)Depreciation andamortization$21,792K (4.21%↑ Y/Y)Cost of revenue,exclusive of depreciation...$20,156K (50.82%↑ Y/Y)Net income$1,169K (-89.42%↓ Y/Y)Income tax expense$4,470K (-20.41%↓ Y/Y)Interest expense$9,767K (-8.24%↓ Y/Y)

GoodRx Holdings, Inc. (GDRX)

GoodRx Holdings, Inc. (GDRX)